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Abstract
Phagocytosis can be induced via the engagement of Fcγ receptors by antibody-opsonized material.
Furthermore, the efficiency of antibody-induced effector functions has been shown to be
dramatically modulated by changes in antibody glycosylation. Because infection can modulate
antibody glycans, which in turn modulate antibody functions, assays capable of determining the
induction of effector functions rather than neutralization or titer provide a valuable opportunity to
more fully characterize the quality of the adaptive immune response. Here we describe a robust
and high-throughput flow cytometric assay to define the phagocytic activity of antigen-specific
antibodies from clinical samples. This assay employs a monocytic cell line that expresses
numerous Fc receptors: including inhibitory and activating, and high and low affinity receptors—
allowing complex phenotypes to be studied. We demonstrate the adaptability of this high-
throughput, flow-based assay to measure antigen-specific antibody-mediated phagocytosis against
an array of viruses, including influenza, HIV, and dengue. The phagocytosis assay format further
allows for simultaneous analysis of cytokine release, as well as determination of the role of
specific Fcγ-receptor subtypes, making it a highly useful system for parsing differences in the
ability of clinical and vaccine induced antibody samples to recruit this critical effector function.
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1. Introduction
Antibodies are potent determinants of the humoral immune response. Though generated as a
result of the interaction of B and T cells, antibodies trigger their cytotoxic effects by
interacting with complement and innate effector cells. Thus they provide a functional link
between the adaptive and innate immune system. They consist of two identical variable
domains (Fv) capable of recognizing a target antigen, and a single constant domain (Fc)
capable of interacting with the effector cells of the immune system. Traditionally, the
epitope recognized by the Fv domains has been thought to be of paramount importance, in
that binding to some epitopes can block, or neutralize the native function of the cognate
antigen. However, the neutralizing activity mediated by the Fv domains of these antibodies
has been found to be insufficient for their protective effects in numerous settings(Clynes et
al., 2000; Johnson and Glennie, 2003; Schmidt and Gessner, 2005; Hessell et al., 2007), and
evidence of the importance of the constant domain's effector function in clinical outcomes
has been accumulating across fields ranging from cancer immunotherapy(Dall'Ozzo et al.,
2004) to autoimmunity(Laszlo et al., 1986) and chronic viral infection(Shore et al., 1974).
Analogously to the Fv escape mechanisms such as mutating surface epitopes, several
pathogens evade the Fc-mediated antibody response by expressing proteases that restrict the
Fc domain(Shakirova et al., 1985; Berasain et al., 2000; Collin et al., 2002; Vidarsson et al.,
2005; Aslam et al., 2008), or glycosidases that remove the sugar residues required for
interaction with Fc receptors(Allhorn et al., 2008). Combined, these evasion mechanisms
and clinical correlates provide strong evidence as to the importance of Fc-based effector
functions in the therapeutic activity of antibodies.
Significantly, while the primary sequence of the constant domain is conserved across
antibodies of a given isotype, the effector functions of distinct antibody isotypes are
profoundly modulated by alterations in the glycosylation profile at asparagine 297 (Asn297)
in the CH2 domain of the antibody, modulating the range of effector responses a given
antibody may elicit(Boyd et al., 1995). The presence or absence of particular sugar groups
on the Fc domain tunes the affinity between IgG and Fc receptors (FcγRs) on effector cells,
and Fc glycoform represents a potent means of modulating antibody activity(Lund et al.,
1996; Raju, 2008). This modulation is bidirectional, as some sugar structures dramatically
affect affinity to stimulatory FcRs, while others are known to inhibit immune
activation(Shields et al., 2002; Kaneko et al., 2006; Nimmerjahn et al., 2007; Scallon et al.,
2007; Raju, 2008; Anthony and Ravetch, 2010).
Similarly, the expression levels of FcγR are also able to modulate antibody activity. Among
IgG binding FcRs, multiple isoforms with distinct functions have been identified: FcγgR1
(high affinity, activating), FcγR2a (low affinity, activating), FcγR2b (low affinity,
inhibitory), and FcγR3 (low affinity, activating). Thus, FcRs for IgG antibodies include both
high and low affinity, as well as activating and inhibitory receptors, each of which may have
differential affinities for various IgG glycoforms, and may be expressed at different levels
on different cell types. Thus, FcγR expression levels combined with Fc glycosylation
patterns represent a highly tunable system for modulating the activity of antibodies.
While numerous classes of innate immune cells express the FcγR involved in antibody-
mediated cytotoxicity, a subset of these are capable of acting as professional phagocytes,
including monocytes, macrophages, neutrophils, dendritic cells, and mast cells. Phagocytic
mechanisms have a demonstrated importance in clearance, antigen presentation, and innate
immune activation. Additionally, antibody-driven phagocytosis enhances infection in
several infectious diseases(Halstead and O'Rourke, 1977; Marchette et al., 1979; Bernard et
al., 1990; Tamura et al., 1991; Fust et al., 1994; Kozlowski et al., 1995) indicating a
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relevance of phagocytic processes not only on protection from, but in susceptibility to
disease, and highlights the significance of this effector function in particular.
Overall, as a potent mechanism of antibody-mediated effector function, antibody-dependent
phagocytosis of immune complexes, opsonized pathogens, and host cells represents an
important connection between the adaptive and innate immune systems. Because antibody
glycosylation patterns and therefore FcR affinity, and immune activity differ, a robust means
to measure this critical effector function may help define qualitative differences in this
effector function during infection, and post-vaccination that may play an important role in
protection. Here we present a high throughput assay capable of measuring the phagocytic
activity of antibodies in clinical samples.
2. Materials and methods
2.1 Cells, control antibodies, viral envelope antigens
THP-1 cells were purchased from ATCC and cultured as recommended. Care was taken to
keep cultures at cell densities below 0.5×106/ml in order to maintain consistent levels of
FcγR expression and assay performance.
A panel of antibodies to FcγR 1, 2, 2A, 2B, and 3 was used (BD Pharmingen, 558592,
555406; Biolegend, 303212; Novus Biologicals, NB100-79947; RD Systems, AF1875) to
determine receptor expression on THP-1 cells. Quantum Simply Cellular bead standards
(Bangs Laboratories, 815) were used to quantify the number of these receptors on THP-1
cells according to the manufacturer's instructions.
Flu hemagglutinin (Sino Biological, 11085-V08H), dengue-2 E peptide (ProsecBio,
DEN-006) and gp120 (Immune Technology, IT-001-0027p YU-2) were biotinylated on
lysine residues using a sulfo-NHS LC biotin reagent (Thermo Scientific, 21935) according
to the manufacturer's instructions. After the reaction, free biotin was removed by extensive
buffer exchange using Amicon centrifugal concentration units of appropriate molecular
weight cutoff.
2.2 Phagocytosis Assay
Biotinylated antigen was incubated with 1 μm fluorescent neutravidin beads (Invitrogen,
F8776) overnight at 4°C. Beads were subsequently spun down and washed twice in PBS-
BSA in order to remove excess unbound antigen, and then resuspended at a final dilution of
1:100 in PBS-BSA. Antigen-coated beads were stored for up to a week at 4°C prior to use.
Saturation of the beads was determined experimentally, via incubation with differing
amounts of antigen. Bead coating conditions that gave the maximal phagocytic score in
conjunction with a control monoclonal antibody were used. 9×105 beads (equivalent of 0.1
μl of supplied suspension, or 10 μl of the dilution described above) were placed in each well
of round bottom 96 well plate. Antibodies were added to each well and the plate was
incubated for a 2 hours at 37°C in order to allow antibodies to bind to the beads. Following
equilibration, 2×104 THP-1 cells were added to each well in a final volume of 200 μl, and
the plate was incubated overnight under standard tissue culture conditions. The next day,
half the culture volume was removed, saved for subsequent multiplexed analysis of cytokine
secretion, and replaced with 100 μl of 4% paraformaldehyde before plates were analyzed by
flow cytometry on a BD LSR II equipped with an HTS plate reader. Samples were mixed
thoroughly (100 μl mix volume, repeated three times), prior to analysis of 30 μl of each
sample, yielding at least 2,000 cell events per sample. A phagocytic score was determined
by gating the samples on events representing cells, and calculated as follows: (% bead
positive × MFI bead positive, or integrated MFI(Darrah et al., 2007)). For ease of
presentation, these scores were then divided by 106. Alternatively, because the first peak of
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bead-positive cells represents cells that have phagocytosed a single bead, it is possible to use
the MFI of this peak to determine the average number of beads phagocytosed by each cell,
with the added advantage of removing instrument variability from the data generated. Error
bars represent standard deviations of at least 3 replicates.
2.3 Confocal and video microscopy
For experiments involving imaging of the THP-1 cells, 1.2×106 cells were incubated with
9×106 beads (equivalent to 1 μl of supplied suspension) saturated with biotinylated human
IgG, or left uncoated in a 3 ml volume in a 12 well plate overnight at either 4°C, or under
standard tissue culture conditions. Cultures were resuspended, 1.5 mls was withdrawn, spun
down, aspirated, and fixed with paraformaldehyde. Following fixation, cells were again spun
down, aspirated, and resuspended in 500 μl of 300 mM sucrose in phosphate buffered saline.
The cell membrane was stained by addition of 5 μl DiI (Invitrogen, V22885) and incubation
at 37°C for 10 minutes. Stained cells were washed twice before being dropped onto a poly-
L-lysine-coated microscope slide, and then imaged on a Zeiss LSM 510 microscope at 63×
magnification, Zeiss Plan-Apochromat DIC, 1.4NA, oil immersion lens. Microscopy
conditions were set such that optical sections were not thicker than the bead diameter.
Additionally, 3-dimensional stacks were collected in order to confirm the internalization
profile of bead particles.
Time-lapse images of phagocytosis were acquired on a Zeiss Axio Observer at 20×
magnification on a Zeiss Axio Observer using a Zeiss Plan-Apochromat, air, 0.8NA lens
over a 14-hour period at a rate of 1 image per minute. Seventy thousand THP-1 cells were
combined with a 30-fold excess of uncoated, red fluorescent beads, and a 30-fold excess of
antibody-coated, green fluorescent beads, and spun down through a collagen matrix at 2,000
rpm onto a coverslip chamber (LabTek, 177402) coated with fibronectin to aid with cell
adherence. At the conclusion of the 14-hour imaging period, a 63× Zeiss Plan-Apochromat
1.4NA oil immersion lens was used to capture representative images at higher
magnification. Image acquisition and analysis was performed using Metamorph software
(Molecular Devices).
2.4 Amnis ImageStreamX Flow Cytometry
Cells were prepared as described for the phagocytosis assay with the addition of an anti-
FcγR2-Alexa647 antibody to label FcγR2, and DAPI to label nuclei, and run on an Amnis
ImageStreamX flow cytometer with 60× magnification. Samples were analyzed with the
IDEAS software platform in order to determine an internalization score. Briefly, a mask
representing the cell membrane was defined by the brightfield image, and an internal mask
was defined by eroding the whole cell mask by 6 pixels, resulting in an area significantly
smaller the cell membrane. An internalization score was calculated as follows: (number of
fluorescent pixels in internal mask) – (number of fluorescent pixels in the entire field of
view).
2.5 Control antibodies and deglycosylation reaction
Human IgG (Sigma, I2511) was biotinylated on lysine residues using a sulfo-NHS LC biotin
reagent (Thermo Scientific, 21935) as described previously. A fraction of the biotinylated
antibody was subsequently deglycosylated using PNGase F (NEB, P0704) according to the
manufacturer's instructions. B12, lala B12, and double and triple mutant B12 were obtained
from Dennis Burton. The anti-dengue antibody 3H5 was purchased from Millipore
(Millipore, MAB10226).
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2.6 Receptor Blocking Experiments
Receptor blocking antibodies to FcγR2 (Abcam, 23336) and FcγR3 (Sigma, F3668) were
used according to the manufacturer's instructions. Cells were preincubated with blocking
antibodies for at least 1 hour prior to being mixed with beads, incubated overnight, and then
analyzed by flow cytometry. Because the blocking antibodies do not necessarily block all
receptor function under the conditions tested, results are presented as the ratio of phagocytic
activity of triple: double mutant for each blocking antibody condition, rather than compared
to untreated controls.
2.7 Patient antibodies
Study individuals were recruited from Ragon Institute cohorts and included patients with
influenza infection, chronically HIV infected individuals, and healthy individuals.
Antibodies were separated from other serum proteins using Melon Gel according to the
manufacturer's instructions (Thermo Scientific, 45206). The study was approved by the
Massachusetts General Hospital Institutional Review Board, and each subject gave written
informed consent. The anti-dengue 2 antibody, 3H5 (Millipore, MAB10226), a mouse
isotype capable of interacting with human FcγR2(Littaua et al., 1990; Flesch et al., 1997)
was used a positive control for dengue-coated beads.
2.8 Luminex Assays
Milliplex cytokine analysis was performed on the Luminex xMap platform following the
manufacturer's instructions (Millipore, custom kit) on supernatants removed from
phagocytosis assay plates.
3. Results and Discussion
3.1 The phagocytosis assay
In addition to their role in neutralization, antibodies are able to mediate a number of
additional functions including the recruitment of innate immune responses to eliminate
antibody-opsonized material. Among these additional antibody mediated functions,
antibodies are able to promote phagocytosis, which may play a profound role in the rapid
containment and clearance of a pathogen following infection. However, robust assays that
are able to capture differences in the quality of antibody-mediated phagocytosis are lacking.
Thus to this end we developed a novel high-throughput assay, using a monocytic-cell line to
provide a platform to tease out antigen-specific antibody mediated phagocytosis. Briefly, the
antibodies of interest are captured on the surface of highly fluorescent latex beads, which are
then incubated overnight with monocytes prior to analysis by flow cytometry. Because the
beads used may be coated with an antigen of choice, this assay allows determination of
antigen-specific phagocytosis without requiring purification of these antibodies.
We employed a widely used monocytic cell line, THP-1(Tsuchiya et al., 1980), which have
been extensively used in studies of phagocytosis of particles including red blood cells,
yeast(Tsuchiya et al., 1982), e.coli(Schiff et al., 1997), staphylococcus(Kapetanovic et al.,
2007), zymosan(Friedland et al., 1993a), and human cells(Tebo et al., 2002; Beum et al.,
2008). They have also been utilized in studies of signaling downstream of phagocytosis,
including cytokine release(Shaw et al., 2000), oxidative burst(Gross et al., 1998), and
receptor phosphorylation(Lee et al., 2007). Moreover because they grow in suspension, they
are an convenient choice for use in a flow cytometry-based assay. Additionally, much is
known about modulation of FcγR expression and maturation in this cell line upon treatment
with various stimulants and cytokines(Fleit and Kobasiuk, 1991). Importantly, as
demonstrated in table 1, THP-1 cells express multiple Fcγ receptors, including FcγR1,
FcγR2, and FcγR3, allowing this cell line to capture effects from a broad range of FcγRs,
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and reflecting the normal FcγR2 expression profile of monocytes (data not shown).
Significantly, these cells also express both subtypes of FcγR2: the activating receptor
implicated in phagocytosis, 2A, and the inhibitory, ITIM motif-containing 2B receptor
(Figure 1). When quantified, we found that FcγR2 is expressed at significantly higher levels
than the other FcγR. While the phagocytic properties of THP-1 cells are increased upon
exposure to stimulants such as PMA(Tsuchiya et al., 1982), these treatments tend to
stimulate non-Fc-dependent phagocytic processes, and can alter FcγR expression profiles
(data not shown). Because they therefore tend to increase baseline phagocytosis levels, and
thereby decrease the relative signal change due to antibody-dependent phagocytosis, the
assay we describe does not utilize any chemical stimulants to mature the THP-1 cells.
Antibodies are captured on the surface of 1.0 um fluorescent microspheres in a 96-well
plate. After incubation at 37°C for at least an hour to allow opsonization to occur, 20,000
THP-1 cells in 200 ul of media are added to each well, and allowed to phagocytose the
antibody-coated microspheres overnight at 37°C. The following day, plates were spun down,
and half of the sample volume is replaced with 4% paraformaldehyde for fixation. Samples
were then run on a BD LSRII cytometer equipped with a high-throughput sampler. Because
the microspheres are exceptionally bright, care was taken in determining acquisition settings
in order to ensure both bead-positive and bead-negative populations were within the
dynamic range of the instrument. To provide a convenient quantitative measure of net
phagocytosis, a phagocytic score was calculated by determining the percentage of cells that
were bead-positive, and multiplying by their mean fluorescence intensity (iMFI)(Darrah et
al., 2007).
Preliminary experiments were carried out using biotinylated bulk human IgG which was
trapped directly on the surface of neutravidin-coated beads. A range of cell (20,000 to
100,000) and bead (9×105 to 9×106) concentrations were evaluated, and the ratio of 45
beads per cell, with 20,000 cells used per well was selected because it yielded the greatest
signal change between antibody coated and non-coated beads. While a value of 15 particles
per phagocytic cell might be a more typical ratio, because our assay format utilizes
suspension cells and does not call for centrifugation to confine beads and cells to a 2-
dimensional plane at the start of the experiment, we have found that a greater particle to cell
ratio and a longer incubation time is optimal.
3.2 Microscopy confirmation of phagocytosis
In order to demonstrate that the beads were in fact phagocytosed, and did not simply
associate with the cell membranes, internalization of the beads was confirmed by confocal
microscopy. Figure 2 presents confocal microscopy images and corresponding flow
cytometry histograms of the phagocytosis of green fluorescent microspheres under various
conditions. Bead uptake, as determined by fluorescence in the flow cytometry readout was
maximal when cells were incubated with antibody-coated beads at 37°C. In contrast, at 0°C,
phagocytosis is impaired, but antibody-coated beads still associate with cells due to specific
interactions between antibodies on the beads and FcγR on the cells, leading to a lower signal
on FACS histograms, and the appearance of surface-associated rather than phagocytosed
beads by confocal microscopy. While FACS signals from uncoated beads at both
temperatures are significantly lower, they are not zero, as the latex beads tend to associate
non-specifically. This level of fluorescence represents a negative control in the evaluation of
experimental samples.
As a second means to verify the internalization of the presumptively phagocytosed beads,
the Amnis ImageStream × imaging flow cytometer, which captures an image of each cell as
it passes through the stream, offers a unique opportunity to perform statistical analysis of
bead internalization on a large number of imaged cells, which is not possible with traditional
Ackerman et al. Page 6
J Immunol Methods. Author manuscript; available in PMC 2012 March 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
confocal microscopy. For these experiments, cell nuclei were stained with DAPI, and FcγR2
was stained with an APC-conjugated antibody. Figure 3A presents cells that were assessed
as bead negative (top), surface-bound bead positive (middle), and internalized bead positive
(bottom). Interestingly, the internalized beads cluster with FcγR2, in some cases, suggesting
that this FcγR may be implicated directly in phagocytosis. Amnis-collected images were
analyzed using the IDEAS software package in order to determine internalization scores of
the beads associated with cells under various conditions. Internalization scores were
calculated by generating a mask representing the membrane of the cell as generated from the
brightfield image, and then subtracting 6 pixels, yielding an internal mask which results in
an area significantly smaller than the cell membrane. The fraction of fluorescent pixels in
the bead channel assigned to locations within the internal mask was calculated as a ratio of
pixels inside versus outside the internal mask. Figure 3B presents the internalization scores
of cells incubated with bare or antibody-coated beads at 0°C and 37°C, and demonstrates
that only under conditions in which antibody-dependent phagocytosis can occur (opsonized,
37°C) were samples scored as having internalized beads—confirming that our flow based
assay captures internalization rather than simple surface association.
3.3 Defining parameters affecting phagocytosis
As a further means to quantitatively demonstrate that the phagocytosis observed is
dependent on the presence of antibody, Figure 3C presents an antibody density dose-
response curve. Beads were incubated with decreasing amounts of antibody, yielding
decreasing phagocytic signal. Similarly, if the antigen density on the beads is decreased but
antibody quantities are maintained, a similar dose-response curve is observed (data not
shown), suggesting that antibody mediated phagocytosis is directly related to both the
frequency of antibody-opsonized targets, but also that the level of phagocytosis can be
enhanced in the presence of increasing quantities of bound antibodies.
Because the interaction between antibodies and FcγR is highly dependent on the
glycosylation state at Asn297 on the Fc domain(Yamaguchi et al., 2006), we next aimed to
determine whether our flow based antibody-mediated phagocytosis assay was equally
dependent on the presence of the antibody glycan. Thus antibodies were deglycosylated
using the broad glycosidase, PNGaseF, and tested in the phagocytosis assay. In fact, the
resulting cleavage between the innermost GlcNAc and asparagine residues of high mannose,
hybrid, and complex oligosaccharides from the N-linked glycosylation site in the Fc domain
of the antibodies ablated phagocytosis, as shown in Figure 4A,B. As a control, equivalent
function of the Fv domains after deglycosylation was experimentally verified by measuring
equivalent antibody binding to beads treated with antibody before and after deglycosylation
(data not shown). Thus overall these data suggest that this assay is able to also read out
differences in phagocytic potential due to the glycan.
3.4 Detection of functional consequences to changes in the Fc domain of recombinant IgG
Next, in order to isolate the phagocytic potential of antigen-specific, rather than bulk
antibodies, gp120, HIV antigen-coated beads were opsonized with antigen-specific
monoclonals to recruit phagocytosis. As a negative control, HIV antibodies directed at
antigens other than gp120 were tested and showed only background phagocytic levels
against gp120-coated beads (data not shown). To test both antigen specificity and Fc-domain
activity, a series of Fc domain mutants (Shields et al., 2001; Hessell et al., 2007) of B12, an
antibody that recognizes HIV gp120 envelope protein, were investigated. Importantly, the
variable domains of each of these antibody variants are identical, and therefore differences
observed in the phagocytic profile of each are due solely to the alterations in their Fc
domains. Double mutant (S239D/I332E) and triple mutant (S239D/I332E/G236A) B12,
which have improved binding to FcγR 1, 2A, 2B, and 3A relative to wildtype Fc domains
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(Shields et al., 2001; Richards et al., 2008) were compared to standard B12, lala B12 (a non
FcγR-binding variant), and a PBS control (Figure 5A). As expected, the non-binding lala
variant demonstrated only background levels (equivalent to PBS control) of phagocytosis at
a range of concentrations, while standard B12 demonstrated high phagocytic scores. Triple
and double mutants gave improved phagocytic scores at low concentrations relative to
standard B12, in agreement with their increasing affinity to FcγRs. These data therefore
demonstrate that this phagocytic assay is strongly modulated by Fc: FcγR affinity, and may
be a useful tool for defining the carbohydrate alterations that may modulate the capacity of a
given antibody to recruit phagocytosis.
3.5 Determining the role of specific FcγR in phagocytosis
Given that THP-1 cells express an array of FcγRs, this assay also provides an opportunity to
tease out the dependence of antibody-mediated phagocytosis on specific FcγR subtypes in
experiments utilizing receptor-blocking antibodies. Cells were preincubated with blocking
antibodies against either FcγR2 (recognizing both 2A and 2B), and FcγR3, and phagocytic
scores were compared to no blocking antibody treatment. While receptor blocking
experiments frequently indicate that blocking FcγR2 decreases phagocytosis, combinations
of receptor-blocking antibodies are more effective, indicating that multiple receptors play a
role in phagocytic processes(Richards et al., 2008). Accordingly these data suggest that this
assay may also permit the evaluation of multiple FcγR subclass interactions.
A pair of Fc domain point mutants of B12, double mutant (S239D/I332E) and triple mutant
(S239D/I332E/G236A), with improved binding to FcγR1, 2A, 2B, and 3A relative to
wildtype Fc domains were tested(Shields et al., 2001; Richards et al., 2008). The additional
point mutation in the triple mutant has been reported to increase antibody affinity to FcγR2A
—imparting specificity to the activating (2A) rather than inhibitory (2B) receptor. Indeed,
the triple mutant was observed to have an improved phagocytic profile relative to the double
mutant, as shown in Figure 5A. As would be expected because their binding to FcγR3A is
equivalent, when this receptor is blocked, the triple mutant still outperforms the double
mutant (Figure 5B). However, when FcγR2 is blocked, the phagocytic activity of the triple
mutant is reduced to equivalence with the double mutant, confirming again that this assay is
a reliable readout of known Fc-related activities.
Interestingly, we have also observed that at high concentrations of antibody, phagocytosis is
reduced (data not shown). This profile reflects the Hook or prozone effect, in which
antibodies exhibit paradoxical activity patterns at high concencentrations(Taborda et al.,
2003). This decrease might be due to free antibody occupying FcγRs on the THP-1 cells and
thereby competing with binding of opsonized particles, as these decreases are observed at
concentrations similar to the Kd of interactions with FcγR2 and 3, and the mutants with
improved affinity to FcγRs reduce phagocytosis at lower concentrations than wildtype
variants. Consistent with thie theory, competition with serum IgG has been cited as a major
factor in driving the high concentrations of antibody required to elicit effector functions in
vivo(Iida et al., 2006). This phenomenon highlights the complexity of Fc domain-driven
effector functions as there are numerous binding interactions taking place: binding of the
variable domain arms to the antigen, and binding of the Fc domain to each FcγR—whether
when antibody is free in solution, or multimerized on opsonized beads resulting in an avidity
advantage.
3.6 Scoring phagocytosis from clinical samples
In order to demonstrate the usefulness of this assay in scoring the phagocytic profile of
antibody samples from patients, we tested antibody samples from patients against beads
coated with antigens from dengue, flu, and HIV. Figure 6A presents the flow cytometry
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histogram traces of a flu patient's antibodies against hemagglutinin (black) and dengue-
coated beads (gray), indicating low levels of uptake against dengue, and high phagocytic
activity against hemagglutinin-coated beads, demonstrating the clear antigen-specific nature
of this assay. For each patient, an antibody dose-response curve was generated. Several
representative phagocytic activity curves of flu patients are presented in Figure 6B,
demonstrating a range of phagocytic activities among these three patients, potentially
reflecting differences in antibody-glycosylation. The antigen specific nature of this activity
was further confirmed using beads coated with various pathogen envelopes. Thus antibody
samples from negative, HIV positive, and flu positive patients were each tested for
phagocytic activity against hemagglutinin (Figure 7A), gp120 (7B), and dengue-coated (7C)
beads, demonstrating specificity for each disease antigen. As a positive control for dengue-
coated beads, a monoclonal anti-dengue antibody was used. Thus overall these data
demonstrate that the phagocytic profile of clinical antibody samples can be reliably
determined by this methodology. Furthermore, by utilizing variant envelope proteins to coat
beads, there exists the possibility to study cross-clade or cross-virus differences in antibody-
dependent phagocytosis.
3.7 Analysis of cytokine secretion
Phagocytosis has been shown to enhance several additional effector functions in phagocytic
cells, including cytokine/chemokine secretion that either enhances or dampens infection
associated inflammation(Friedland et al., 1993b). Thus we were intrigued to next define
whether this high-throughput flow based antibody-mediated phagocytosis assay could also
provide an opportunity to characterize changes in the activity of phagocytic cells following
the induction of phagocytosis. Thus cytokine release was determined utilizing a luminex
assay. Numerous cytokines reported to be produced by monocytes, including both
immunostimulatory and immunosuppressive cytokines, were monitored concurrently. As
negative controls, untreated cells, and cells treated with uncoated beads were tested for their
secretion profiles, and beads were tested at a range of concentrations. Secretion of several
cytokines in the panel was increased in a dose-dependent manner (Figure 8). Because
different receptor usage profiles may trigger signaling via different pathways and therefore
lead to differing cytokine release profiles, profiling cell supernatants in this way may
provide an additional point of comparison between patient samples. Thus, while THP-1 cells
have been used frequently in studies of cytokine release and the oxidative burst which
occurs following phagocytosis(Gross et al., 1998; Kurosaka et al., 1998; Shaw et al., 2000;
Miyazawa et al., 2007), the specific cytokine release profiles for this cell line may not
correspond to signals occurring naturally during phagocytosis mediated by heterogeneous
populations of primary cells, however these data may provide more profound understanding
of qualitatively unique antibody effector functions in this high-throughput cell line based
screening method that can be later teased out on primary cells.
3.8 Defining the durability of antibody-mediated phagocytosis
Lastly, given that THP-1 cells released a number of proinflammatory cytokines/chemokines
after co-culture with antibody-coated beads, we were interested to determine whether under
such inflammatory conditions activated THP-1 cells would begin to take up beads in an
antibody-independent manner by using time-lapse microscopy. For these experiments, both
antibody-coated (green) and bare (red) beads were incubated with cells and 14-hour time-
lapse microscopy images were collected. Figure 9A presents the first and last frames of
movies included as Movies 1 and 2 in the online version, and demonstrates the scattered
distribution of both antibody-coated and bare beads at initial timepoints, but punctate, cell-
associated distribution of antibody-coated beads at the conclusion of the experiment. Movie
3 presents a magnification of the phagocytic behavior observed. Despite being stimulated by
the presence of opsonized particles, the monocytes retain a striking preference for
Ackerman et al. Page 9
J Immunol Methods. Author manuscript; available in PMC 2012 March 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
phagocytosing antibody-coated beads, and are frequently observed to contact both bead
types but only take up the opsonized beads. Figure 9B presents still images at 63×
magnification, and again clearly demonstrates the lack of uptake in the absence of antibody.
Thus these data strongly suggest that even under inflammatory conditions, the THP-1 cells
used in this assay retain the capacity to selectively phagocytose antibody-opsonized
material.
3.9 Assay Performance Criteria
The performance metrics associated with the phagocytosis assay presented here include
linearity under conditions of limiting antibody (Figure 4C); precise antigen specificity, as
demonstrated by the analysis of patient samples with mismatched antigen beads, as well as
testing of mismatched monoclonals (Figure 7); precise Fc domain specificity, as
demonstrated by experiments with deglycosylated and point-mutated Fc domains; sensitivity
down to 5 ng/ml of monoclonal antibody (below the Fv Kd), and 50 ng/ml for patient
antibody samples, although these values are dependent on the Fv domain affinity as well as
titer; and high reproducibility, with coefficients of variation of less than 0.10 on assays
conducted on different days, and 0.06 within the same experiment. Additionally, a
significant correlation between phagocytosis in assays utilizing THP-1 cells and primary
monocytes for a set of patient samples has also been observed, suggesting that the results
generated from this cell line provide relevant information related to results anticipated from
primary cells (data not shown). However we anticipate that the primary utility of the assay
will be in differentiating the ability of clinical antibody samples to induce phagocytosis
rather than in reproducing the complex phagocytic processes occurring in heterogeneous
populations of primary cells, which can later be parsed out following identification of
unique antibody populations that mediate robust activity in this high-throughput assay.
4. Conclusion
Overall, because innate immune recruiting effector functions have been underappreciated in
the protective capacity of even neutralizing antibodies, and phagocytosis might be important
in the initial control and clearance of pathogens, an assay capable of measuring this effector
function represents an important means of characterizing the immune response to infection
or vaccination. Challenges related to the study of effector functions include the large number
of FcγRs with variable affinities, expression levels, and signaling capacities. Beyond this,
antibody-dependent complement deposition, coupled with defects in phagocytes due to
infection, and the prosaic concentration effects of antibodies further confound the study of
phagocytosis. Despite these challenges, we have described a robust and high-throughput
flow cytometric assay to define the phagocytic activity of antibodies from clinical samples.
Because this assay employs a widely utilized monocytic cell line that expresses numerous
FcγRs, including both inhibitory and activating, complex phenotypes can be studied.
Furthermore, the standardization permitted by utilizing a cell line is important for large scale
monitoring of antibody samples from infection and vaccination. We have demonstrated that
the assay described here is able to resolve the involvement of individual FcγRs, monitor
cytokine release, and detect differences in phagocytosis due to the glycan structure of
antigen-specific antibodies, making it a highly useful system for parsing differences in this
potentially vital antibody-dependent effector function in both infection and vaccine-
mediated protection.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Ackerman et al. Page 10
J Immunol Methods. Author manuscript; available in PMC 2012 March 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
References
Allhorn M, Olin AI, Nimmerjahn F, Collin M. Human IgG/Fc gamma R interactions are modulated by
streptococcal IgG glycan hydrolysis. PLoS One 2008;3:e1413. [PubMed: 18183294]
Anthony RM, Ravetch JV. A novel role for the IgG Fc glycan: the anti-inflammatory activity of
sialylated IgG Fcs. J Clin Immunol 2010;30 1:S9–14. [PubMed: 20480216]
Aslam A, Quinn P, McIntosh RS, Shi J, Ghumra A, McKerrow JH, Bunting KA, Dunne DW,
Doenhoff MJ, Morrison SL, Zhang K, Pleass RJ. Proteases from Schistosoma mansoni cercariae
cleave IgE at solvent exposed interdomain regions. Mol Immunol 2008;45:567–74. [PubMed:
17631966]
Berasain P, Carmona C, Frangione B, Dalton JP, Goni F. Fasciola hepatica: parasite-secreted
proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and
identification of the immunoglobulin fragments produced. Exp Parasitol 2000;94:99–110. [PubMed:
10673346]
Bernard J, Reveil B, Najman I, Liautaud-Roger F, Fouchard M, Picard O, Cattan A, Mabondzo A,
Laverne S, Gallo RC, et al. Discriminating between protective and enhancing HIV antibodies. AIDS
Res Hum Retroviruses 1990;6:243–9. [PubMed: 2109624]
Beum PV, Mack DA, Pawluczkowycz AW, Lindorfer MA, Taylor RP. Binding of rituximab,
trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1
cells and monocytes. J Immunol 2008;181:8120–32. [PubMed: 19018005]
Boyd PN, Lines AC, Patel AK. The effect of the removal of sialic acid, galactose and total
carbohydrate on the functional activity of Campath-1H. Mol Immunol 1995;32:1311–8. [PubMed:
8643100]
Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytoxicity
against tumor targets. Nat Med 2000;6:443–6. [PubMed: 10742152]
Collin M, Svensson MD, Sjoholm AG, Jensenius JC, Sjobring U, Olsen A. EndoS and SpeB from
Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun
2002;70:6646–51. [PubMed: 12438337]
Dall'Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, Bardos P, Watier H, Thibault G.
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on
the concentration-effect relationship. Cancer Res 2004;64:4664–9. [PubMed: 15231679]
Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed
SG, Morris SL, Roederer M, Seder RA. Multifunctional TH1 cells define a correlate of vaccine-
mediated protection against Leishmania major. Nat Med 2007;13:843–50. [PubMed: 17558415]
Fleit HB, Kobasiuk CD. The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc
gamma RII. J Leukoc Biol 1991;49:556–65. [PubMed: 1709200]
Flesch BK, Achtert G, Neppert J. Inhibition of monocyte and polymorphonuclear granulocyte immune
phagocytosis by monoclonal antibodies specific for Fc gamma RI, II and III. Ann Hematol
1997;74:15–22. [PubMed: 9031610]
Friedland JS, Shattock RJ, Griffin GE. Phagocytosis of Mycobacterium tuberculosis or particulate
stimuli by human monocytic cells induces equivalent monocyte chemotactic protein-1 gene
expression. Cytokine 1993a;5:150–6. [PubMed: 7687473]
Friedland JS, Shattock RJ, Johnson JD, Remick DG, Holliman RE, Griffin GE. Differential cytokine
gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma
gondii compared with Mycobacterium tuberculosis. Clin Exp Immunol 1993b;91:282–6.
[PubMed: 8428393]
Fust G, Toth FD, Kiss J, Ujhelyi E, Nagy I, Banhegyi D. Neutralizing and enhancing antibodies
measured in complement-restored serum samples from HIV-1-infected individuals correlate with
immunosuppression and disease. AIDS 1994;8:603–9. [PubMed: 7914732]
Gross A, Dugas N, Spiesser S, Vouldoukis I, Damais C, Kolb JP, Dugas B, Dornand J. Nitric oxide
production in human macrophagic cells phagocytizing opsonized zymosan: direct characterization
by measurement of the luminol dependent chemiluminescence. Free Radic Res 1998;28:179–91.
[PubMed: 9645394]
Ackerman et al. Page 11
J Immunol Methods. Author manuscript; available in PMC 2012 March 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by
non-neutralizing antibody. J Exp Med 1977;146:201–17. [PubMed: 406347]
Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci
G, Forthal DN, Parren PW, Marx PA, Burton DR. Fc receptor but not complement binding is
important in antibody protection against HIV. Nature 2007;449:101–4. [PubMed: 17805298]
Iida S, Misaka H, Inoue M, Shibata M, Nakano R, Yamane-Ohnuki N, Wakitani M, Yano K, Shitara
K, Satoh M. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum
immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to
FcgammaRIIIa. Clin Cancer Res 2006;12:2879–87. [PubMed: 16675584]
Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin
Oncol 2003;30:3–8. [PubMed: 12652458]
Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting
from Fc sialylation. Science 2006;313:670–3. [PubMed: 16888140]
Kapetanovic R, Nahori MA, Balloy V, Fitting C, Philpott DJ, Cavaillon JM, Adib-Conquy M.
Contribution of phagocytosis and intracellular sensing for cytokine production by Staphylococcus
aureus-activated macrophages. Infect Immun 2007;75:830–7. [PubMed: 17118979]
Kozlowski PA, Black KP, Shen L, Jackson S. High prevalence of serum IgA HIV-1 infection-
enhancing antibodies in HIV-infected persons. Masking by IgG. J Immunol 1995;154:6163–73.
[PubMed: 7751656]
Kurosaka K, Watanabe N, Kobayashi Y. Production of proinflammatory cytokines by phorbol
myristate acetate-treated THP-1 cells and monocyte-derived macrophages after phagocytosis of
apoptotic CTLL-2 cells. J Immunol 1998;161:6245–9. [PubMed: 9834112]
Laszlo A, Petri I, Ilyes M. Antibody dependent cellular cytotoxicity (ADCC)-reaction and an in vitro
steroid sensitivity test of peripheral lymphocytes in children with malignant haematological and
autoimmune diseases. Acta Paediatr Hung 1986;27:23–9. [PubMed: 3730180]
Lee JS, Nauseef WM, Moeenrezakhanlou A, Sly LM, Noubir S, Leidal KG, Schlomann JM, Krystal
G, Reiner NE. Monocyte p110alpha phosphatidylinositol 3-kinase regulates phagocytosis, the
phagocyte oxidase, and cytokine production. J Leukoc Biol 2007;81:1548–61. [PubMed:
17369495]
Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement
of dengue virus infection. J Immunol 1990;144:3183–6. [PubMed: 2139079]
Lund J, Takahashi N, Pound JD, Goodall M, Jefferis R. Multiple interactions of IgG with its core
oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and
influence the synthesis of its oligosaccharide chains. J Immunol 1996;157:4963–9. [PubMed:
8943402]
Marchette NJ, Halstead SB, O'Rourke T, Scott RM, Bancroft WH, Vanopruks V. Effect of immune
status on dengue 2 virus replication in cultured leukocytes from infants and children. Infect Immun
1979;24:47–50. [PubMed: 572345]
Miyazawa M, Ito Y, Yoshida Y, Sakaguchi H, Suzuki H. Phenotypic alterations and cytokine
production in THP-1 cells in response to allergens. Toxicol In Vitro 2007;21:428–37. [PubMed:
17118622]
Nimmerjahn F, Anthony RM, Ravetch JV. Agalactosylated IgG antibodies depend on cellular Fc
receptors for in vivo activity. Proc Natl Acad Sci U S A 2007;104:8433–7. [PubMed: 17485663]
Raju TS. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin
Immunol 2008;20:471–8. [PubMed: 18606225]
Richards JO, Karki S, Lazar GA, Chen H, Dang W, Desjarlais JR. Optimization of antibody binding to
FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol Cancer Ther 2008;7:2517–
27. [PubMed: 18723496]
Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS. Higher levels of sialylated Fc glycans in
immunoglobulin G molecules can adversely impact functionality. Mol Immunol 2007;44:1524–34.
[PubMed: 17045339]
Schiff DE, Kline L, Soldau K, Lee JD, Pugin J, Tobias PS, Ulevitch RJ. Phagocytosis of gram-
negative bacteria by a unique CD14-dependent mechanism. J Leukoc Biol 1997;62:786–94.
[PubMed: 9400820]
Ackerman et al. Page 12
J Immunol Methods. Author manuscript; available in PMC 2012 March 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Schmidt RE, Gessner JE. Fc receptors and their interaction with complement in autoimmunity.
Immunol Lett 2005;100:56–67. [PubMed: 16125792]
Shakirova RG, German GP, Chernokhvostova EV. IgA protease activity of microbes in the genus
Bordetella. Zh Mikrobiol Epidemiol Immunobiol 1985:10–3. [PubMed: 2864769]
Shaw TC, Thomas LH, Friedland JS. Regulation of IL-10 secretion after phagocytosis of
Mycobacterium tuberculosis by human monocytic cells. Cytokine 2000;12:483–6. [PubMed:
10857763]
Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG. Lack of fucose
on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and
antibody-dependent cellular toxicity. J Biol Chem 2002;277:26733–40. [PubMed: 11986321]
Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA,
Presta LG. High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc
gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the
Fc gamma R. J Biol Chem 2001;276:6591–604. [PubMed: 11096108]
Shore SL, Nahmias AJ, Starr SE, Wood PA, McFarlin DE. Detection of cell-dependent cytotoxic
antibody to cells infected with herpes simplex virus. Nature 1974;251:350–2. [PubMed: 4372535]
Taborda CP, Rivera J, Zaragoza O, Casadevall A. More is not necessarily better: prozone-like effects
in passive immunization with IgG. J Immunol 2003;170:3621–30. [PubMed: 12646626]
Tamura M, Webster RG, Ennis FA. Antibodies to HA and NA augment uptake of influenza A viruses
into cells via Fc receptor entry. Virology 1991;182:211–9. [PubMed: 2024464]
Tebo AE, Kremsner PG, Luty AJ. Fcgamma receptor-mediated phagocytosis of Plasmodium
falciparum-infected erythrocytes in vitro. Clin Exp Immunol 2002;130:300–6. [PubMed:
12390319]
Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K. Induction of maturation
in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982;42:1530–6.
[PubMed: 6949641]
Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and
characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer
1980;26:171–6. [PubMed: 6970727]
Vidarsson G, Overbeeke N, Stemerding AM, van den Dobbelsteen G, van Ulsen P, van der Ley P,
Kilian M, van de Winkel JG. Working mechanism of immunoglobulin A1 (IgA1) protease:
cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1
Protease. Infect Immun 2005;73:6721–6. [PubMed: 16177349]
Yamaguchi Y, Nishimura M, Nagano M, Yagi H, Sasakawa H, Uchida K, Shitara K, Kato K.
Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as
revealed by NMR spectroscopy. Biochim Biophys Acta 2006;1760:693–700. [PubMed:
16343775]
Ackerman et al. Page 13
J Immunol Methods. Author manuscript; available in PMC 2012 March 7.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. Expression of FcγR2A and 2B
THP-1 cells were labeled with antibodies specific for the extracellular domain of FcγR2A,
the Fc receptor implicated in phagocytosis, and the intracellular domain of the inhibitory
receptor FcγR2B. Cells labeled with secondary only are traced in black, cells labeled with
primary and secondary antibody are traced in gray.
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Figure 2. Phagocytosis Assay
Confocal microscopy images and flow cytometry histograms of phagocytosis of green
fluorescent beads with or without antibody coating, at 37°C or 0°C. For confocal
microscopy, membrane was stained red with the membrane dye, DiI. Histograms represent
the fluorescent signal from cell-associated beads. Bead uptake is maximal under conditions
where FcγR-mediated phagocytosis can occur.
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Figure 3. Confirmation of phagocytosis
A. Representative images captured by the Amnis ImageStreamX Flow Cytometer of cells
without any beads (top), surface bound beads (middle), or internalized beads (bottom).
Nuclei are stained blue, beads green, and FcγR2 in red. B. Internalization score calculated
by Amnis' IDEAS software, indicating internalization of beads when coated by antibody at
37°C, and minimal internalization of beads without antibody-coating, or when incubated at
0°C. C. Dependence of phagocytic score on the density of antibody coating on the surface of
the beads.
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Figure 4. Dependence on antibody glycosylation state
A. Phagocytic scores and B. Flow cytometry histograms depicting cells incubated with
uncoated (-Ab), antibody-coated (+Ab), and deglycosylated antibody-coated
(+deglycosylated Ab) fluorescent beads. Uptake of antibody-coated beads is highly
dependent on antibody glycosylation state.
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Figure 5. Dependence on specific FcγR
A. gp120-coated beads were incubated with b12 variants triple, double, standard and lala (Fc
binding knockout) at varying concentrations (100, 20, 5 ng/ml), and the phagocytic score
was determined. B. Receptor blocking experiments in which either FcγR2 or FcγR3 was
blocked by preincubation with an anti- FcγR antibody. Results are presented as the ratio of
the phagocytic score for the variant:double mutant at each given condition.
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Figure 6. Antigen specificity of antibody-dependent phagocytosis
A. FACS histogram showing representative data for flu antibodies incubated with dengue
beads (gray) or hemagglutinin beads (black). B. Antibody dose-response curve from a single
replicate for 3 flu patients are depicted.
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Figure 7. Antibody-dependent phagocytosis of patient samples
A. The dot plot represents maximum phagocytic scores of antibodies from negative, HIV
positive, or flu positive individuals against hemagglutinin-coated beads. B. Diagrams show
phagocytic scores of antibodies from negative, HIV positive, or flu positive individuals
against gp120-coated beads. C. Finally, the figure demonstrates phagocytic scores of
antibodies from negative, HIV positive, flu positive individuals, or a mouse IgG2A anti-
dengue monoclonal against dengue antigen-coated beads.
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Figure 8. Cytokine release
Line graphs represent multiplexed analysis of phagocytic scores and corresponding cytokine
secretion from cells left untreated, incubated with uncoated beads (circles) or antibody-
coated beads (squares) showing strong antibody and dose-dependent phagocytosis-induced
release of several cytokines
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Figure 9. Time-lapse microscopy of phagocytosis
Antibody-coated (green) and bare (red) beads were incubated with THP-1 cells on
coverslips for time lapse microscopy, demonstrating antibody-specific uptake. A. 20×
magnification still images representing the first (left) and final (right) frames from two 14
hour experiments. B. Representative 63× magnification images at 14 hours.
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